Covid update
Alexander Willemse, PhD, MSc

Alexander Willemse, PhD, MSc

Chief Executive Officer

send a mail

Joined BioConnection in 2008

Before joining BioConnection, Alexander worked for several (pharmaceutical) companies. He started his career at Organon NV in 1998 and moved to OctoPlus in 2003 as managing director of Octoplus Development BV (OPD). Since 2008, he is the CEO of BioConnection BV.

Alexander studied chemical engineering at the Delft University of Technology, where he also obtained his PhD. He gave a lot of courses such as “Particle size measurement for aerosol systems” at the University of California (UCLA) and “Measuring techniques for biophysical systems” at the University of Leuven, Belgium. For the Top Institute Pharma in the Netherlands, he contributed to the course “Drug Development Simulation” as CMC expert in 2007, 2008 and 2009. In the last years he contributed to this course via Learning by Simulation. He is the (co-)author of more than 20 scientific publications. When having some hours to spent he loves, besides being with his family, to be on his mountainbike and in the winter you can find him on the skislopes anywhere in the world.

“It’s amazing to see how the company has grown the last couple of years. Especially the acquisition of our own manufacturing plant in 2016 was a major step forward. I find this work very diverse and challenging. But mainly it is our people that make the difference. It is a real team with a great spirit that go the extra mile. Combine this with a good sense of humor and a common sense attitude and you have a winning team. Our main aim is to give our costumers the best products and services possible. BioConnection is your excellent choice for the Fill & Finish of clinical, small and large-scale batches, because of our state-of-the-art cGMP facilities, our team and our experience in developing and manufacturing bio-pharmaceutical products.

We offer a broad range of support services for all stages and aspects of biopharmaceutical (CMC) development. This ranges from formulation development, process development, analytical development, stability studies to scale-up and packaging of final products to support clinical trials and commercial activities. So, with BioConnection you will be in good hands, saving a great deal of time and money”.


Covid-19 update BioConnection

BioConnection has taken precautions related to the global outbreak of the Covid-19 virus. To start with; we are currently in full operation and running on-schedule with regard to our planned productions. Our production department is on full strength and we have no shortages of material(s) nor do we foresee them.

For our personnel we are following the guidelines as issued by the Dutch National Institute for Public Health and the Environment, RIVM ( This means that people stay at home when they show (early) symptoms connected to Covid-19. Furthermore BioConnection employees work from home as much as possible. We avoid shaking hands and keep distance from each other. We take every precaution as advised to prevent the spread of the Covid-19 virus and will fully comply to the requests as stated and/or enforced by the authorities.

Our expansion project ( is running as planned to start GMP production in Q2 2021. We stay in close contact with our suppliers for the production equipment.

We review for Covid policy changes by the authorities on a daily base and adapt to them. If changes occur, this statement will be updated accordingly so you always have the latest information. In case you have any questions, please do not hesitate to contact us via our general number or website. Current customers of BioConnection, can contact their dedicated program manager. In case you want BioConnection to become a partner in your development or manufacturing, please contact our Business Development department via

The BioConnection Management Team.

You have Successfully Subscribed!